99 related articles for article (PubMed ID: 26377315)
1. O-GlcNAcylation of connexin 40: a sweet connection between diabetes and endothelial cell dysfunction? Focus on "O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice".
Issad T
Am J Physiol Cell Physiol; 2015 Nov; 309(9):C590-2. PubMed ID: 26377315
[No Abstract] [Full Text] [Related]
2. O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice.
Makino A; Dai A; Han Y; Youssef KD; Wang W; Donthamsetty R; Scott BT; Wang H; Dillmann WH
Am J Physiol Cell Physiol; 2015 Nov; 309(9):C593-9. PubMed ID: 26269457
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart.
Hu Y; Belke D; Suarez J; Swanson E; Clark R; Hoshijima M; Dillmann WH
Circ Res; 2005 May; 96(9):1006-13. PubMed ID: 15817886
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of hexokinase 2 reduces mitochondrial calcium overload in coronary endothelial cells of type 2 diabetic mice.
Pan M; Han Y; Basu A; Dai A; Si R; Willson C; Balistrieri A; Scott BT; Makino A
Am J Physiol Cell Physiol; 2018 Jun; 314(6):C732-C740. PubMed ID: 29513568
[TBL] [Abstract][Full Text] [Related]
5. A bittersweet modification: O-GlcNAc and cardiac dysfunction.
Jones SP
Circ Res; 2005 May; 96(9):925-6. PubMed ID: 15890978
[No Abstract] [Full Text] [Related]
6. Overexpression of p53 due to excess protein O-GlcNAcylation is associated with coronary microvascular disease in type 2 diabetes.
Si R; Zhang Q; Tsuji-Hosokawa A; Watanabe M; Willson C; Lai N; Wang J; Dai A; Scott BT; Dillmann WH; Yuan JX; Makino A
Cardiovasc Res; 2020 May; 116(6):1186-1198. PubMed ID: 31504245
[TBL] [Abstract][Full Text] [Related]
7. Endothelial Glycocalyx as a Shield Against Diabetic Vascular Complications: Involvement of Hyaluronan and Hyaluronidases.
Dogné S; Flamion B; Caron N
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1427-1439. PubMed ID: 29880486
[TBL] [Abstract][Full Text] [Related]
8. Carbon monoxide and biliverdin prevent endothelial cell sloughing in rats with type I diabetes.
Rodella L; Lamon BD; Rezzani R; Sangras B; Goodman AI; Falck JR; Abraham NG
Free Radic Biol Med; 2006 Jun; 40(12):2198-205. PubMed ID: 16785033
[TBL] [Abstract][Full Text] [Related]
9. Protective role of SIRT1 in diabetic vascular dysfunction.
Orimo M; Minamino T; Miyauchi H; Tateno K; Okada S; Moriya J; Komuro I
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):889-94. PubMed ID: 19286634
[TBL] [Abstract][Full Text] [Related]
10. A single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-D glucosaminidase is associated with type 2 diabetes in Mexican Americans.
Lehman DM; Fu DJ; Freeman AB; Hunt KJ; Leach RJ; Johnson-Pais T; Hamlington J; Dyer TD; Arya R; Abboud H; Göring HH; Duggirala R; Blangero J; Konrad RJ; Stern MP
Diabetes; 2005 Apr; 54(4):1214-21. PubMed ID: 15793264
[TBL] [Abstract][Full Text] [Related]
11. Akt/eNOS pathway activation in endothelium-dependent relaxation is preserved in aortas from female, but not from male, type 2 diabetic mice.
Taguchi K; Matsumoto T; Kamata K; Kobayashi T
Pharmacol Res; 2012 Jan; 65(1):56-65. PubMed ID: 21933713
[TBL] [Abstract][Full Text] [Related]
12. Protein tyrosine phosphatase 1B impairs diabetic wound healing through vascular endothelial growth factor receptor 2 dephosphorylation.
Zhang J; Li L; Li J; Liu Y; Zhang CY; Zhang Y; Zen K
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):163-74. PubMed ID: 25395617
[TBL] [Abstract][Full Text] [Related]
13. Use of angiotensin-converting enzyme inhibitors in patients with diabetes and coronary artery disease.
Dell'Italia LJ; Rocic P; Lucchesi PA
Curr Probl Cardiol; 2002 Jan; 27(1):6-36. PubMed ID: 11815752
[No Abstract] [Full Text] [Related]
14. In Vitro Biochemical Assays for O-GlcNAc-Processing Enzymes.
Kim EJ
Chembiochem; 2017 Aug; 18(15):1462-1472. PubMed ID: 28474822
[TBL] [Abstract][Full Text] [Related]
15. Glyoxalase-1 overexpression in bone marrow cells reverses defective neovascularization in STZ-induced diabetic mice.
Vulesevic B; McNeill B; Geoffrion M; Kuraitis D; McBane JE; Lochhead M; Vanderhyden BC; Korbutt GS; Milne RW; Suuronen EJ
Cardiovasc Res; 2014 Feb; 101(2):306-16. PubMed ID: 24259499
[TBL] [Abstract][Full Text] [Related]
16. The hexosamine signaling pathway: deciphering the "O-GlcNAc code".
Love DC; Hanover JA
Sci STKE; 2005 Nov; 2005(312):re13. PubMed ID: 16317114
[TBL] [Abstract][Full Text] [Related]
17. Role of mitochondrial dysfunction in hyperglycaemia-induced coronary microvascular dysfunction: Protective role of resveratrol.
Joshi MS; Williams D; Horlock D; Samarasinghe T; Andrews KL; Jefferis AM; Berger PJ; Chin-Dusting JP; Kaye DM
Diab Vasc Dis Res; 2015 May; 12(3):208-16. PubMed ID: 25767181
[TBL] [Abstract][Full Text] [Related]
18. Taurine rescues vascular endothelial dysfunction in streptozocin-induced diabetic rats: correlated with downregulation of LOX-1 and ICAM-1 expression on aortas.
Wang LJ; Yu YH; Zhang LG; Wang Y; Niu N; Li Q; Guo LM
Eur J Pharmacol; 2008 Nov; 597(1-3):75-80. PubMed ID: 18796303
[TBL] [Abstract][Full Text] [Related]
19. Adverse epigenetic signatures by histone methyltransferase Set7 contribute to vascular dysfunction in patients with type 2 diabetes mellitus.
Paneni F; Costantino S; Battista R; Castello L; Capretti G; Chiandotto S; Scavone G; Villano A; Pitocco D; Lanza G; Volpe M; Lüscher TF; Cosentino F
Circ Cardiovasc Genet; 2015 Feb; 8(1):150-8. PubMed ID: 25472959
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of protein kinase C β ameliorates impaired angiogenesis in type I diabetic mice complicating myocardial infarction.
Ikeda A; Matsushita S; Sakakibara Y
Circ J; 2012; 76(4):943-9. PubMed ID: 22313801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
